Personalized blood pressure control after thrombectomy boosts 90-day stroke recovery

The HOPE clinical trial demonstrated that personalizing blood pressure targets based on individual cerebral reperfusion after stroke thrombectomy significantly improves functional recovery at 90 days without increasing complication risks, representing a meaningful advance in post-stroke care protocols.

This does not prove the approach works universally across all stroke subtypes, patient populations, or long-term outcomes beyond 90 days; implementation and adoption in clinical practice remain separate questions.